Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Assets: 2012-2025

Historic Assets for Veracyte (VCYT) over the last 12 years, with Sep 2025 value amounting to $1.4 billion.

  • Veracyte's Assets rose 7.28% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 7.28%. This contributed to the annual value of $1.3 billion for FY2024, which is 16.60% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Assets is $1.4 billion, which was up 1.76% from $1.3 billion recorded in Q2 2025.
  • Veracyte's Assets' 5-year high stood at $1.4 billion during Q3 2025, with a 5-year trough of $1.0 billion in Q1 2021.
  • For the 3-year period, Veracyte's Assets averaged around $1.2 billion, with its median value being $1.2 billion (2024).
  • Its Assets has fluctuated over the past 5 years, first spiked by 300.19% in 2021, then declined by 5.09% in 2022.
  • Quarterly analysis of 5 years shows Veracyte's Assets stood at $1.2 billion in 2021, then declined by 2.64% to $1.2 billion in 2022, then fell by 3.59% to $1.1 billion in 2023, then grew by 16.60% to $1.3 billion in 2024, then climbed by 7.28% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.